Pharmaceutical Key Trends 2011 Prescription Pharmaceutical Sales Overview

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Oct 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Chemical & Pharmaceutical Plant Construction in South Africa to 2018: Market Databook

Chemical & Pharmaceutical Plant Construction in South Africa to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in South Africa to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: South Africa

Chemical & Pharmaceutical Plants Construction in Austria to 2018: Market Databook

Chemical & Pharmaceutical Plants Construction in Austria to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical & Pharmaceutical Plants Construction in Austria to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: Austria

Chemical & Pharmaceutical Plant Construction in Poland to 2018: Market Databook

Chemical & Pharmaceutical Plant Construction in Poland to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in Poland to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: Poland

Chemical & Pharmaceutical Plant Construction in the Philippines to 2018: Market Databook

Chemical & Pharmaceutical Plant Construction in the Philippines to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in the Philippines to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: Philippines

Chemical and Pharmaceutical Plants Construction in Hong Kong to 2018: Market Databook

Chemical and Pharmaceutical Plants Construction in Hong Kong to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical and Pharmaceutical Plants Construction in Hong Kong to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical

Arrhythmia Research Technology, Inc.

Arrhythmia Research Technology, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Arrhythmia Research Technology, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pathology

Ginger Beef Corporation

Ginger Beef Corporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 54 pages

A textual analysis of the financial results for Ginger Beef Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication | Countries: Canada

Chemical & Pharmaceutical Plant Construction in Colombia to 2018: Market Databook

Chemical & Pharmaceutical Plant Construction in Colombia to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • October 2014
  • 33 pages

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in Colombia to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: Colombia

Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Hubei Biocause Pharmaceutical Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.